Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation

Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...

Fuld beskrivelse

Gespeichert in:
Bibliografiske detaljer
Hovedforfatter: Lückel, Christina
Andre forfattere: Huber, Magdalena (Prof. Dr.) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Sprog:engelsk
Udgivet: Philipps-Universität Marburg 2018
Fag:
multiple sclerosis
IL-17
Multiple Sklerose
ROS
Tc17 cells
Dimethyl fumarate
Tc17 Zellen
Dimethylfumarat
Medizin
Medical sciences Medicine
Online adgang:PDF-Volltext
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
No citations were found for this record.

Lignende værker